Obesity and endoplasmic reticulum (ER) stresses by Yamini B. Tripathi & Vivek Pandey
REVIEW ARTICLE
published: 07 August 2012
doi: 10.3389/fimmu.2012.00240
Obesity and endoplasmic reticulum (ER) stresses
Yamini B. Tripathi* and Vivek Pandey
Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
Edited by:
Masaaki Murakami, Osaka
University, Japan
Reviewed by:
Daisuke Kamimura, Osaka
University, Japan
Hideki Ogura, Osaka University,
Japan
*Correspondence:
Yamini B. Tripathi, Department of
Medicinal Chemistry, Institute of
Medical Sciences, Banaras Hindu
University, Varanasi-221005,
UP, India.
e-mail: yaminiok@yahoo.com
In obesity, the adipose cells behave as inflammatory source and result to low grade
inflammation. This systemic inflammation along with oxidative stress is a silent killer
and damages other vital organs also. High metabolic process, induced due to high
nutritional intake, results to endoplasmic reticulum (ER) stress and mitochondrial stress.
This review describes the triggering factor and basic mechanism behind the obesity
mediated these stresses in relation to inflammation. Efforts have been made to describe
the effect-response cycle between adipocytes and non-adipocyte cells with reference to
metabolic syndrome (MS).
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INTRODUCTION
Increased body mass index (BMI) is associated with metabolic
syndrome (MS), a cluster of central obesity, insulin resistance,
impaired glucose tolerance, hypertension, atherosclerosis, and
dyslipidemia. It is accompanied with low grade inflamma-
tion, vascular endothelial dysfunction, high adipokines, hypoxia,
oxidative, andmetabolic stress. In obesity, the adipose cells behave
as inflammatory source and result to systemic inflammation.
High caloric nutrition, oxidative stress, and dyslipidaemia are the
basic factors, resulting to high circulating FFA, insulin resistance,
and macrophage dysfunction. The basic cause is the behavioral
change in adipocytes, which is primarily mediated through ER
dysfunction and further linked to oxidative stress and mito-
chondrial dysfunction (Figure 1). The whole process changes the
phenotype of macrophages, through its polarized differentiation,
ultimately setting up of low grade inflammation. Here, we have
discussed the initiating causes of fat deposition in adipose and
non-adipose tissue and their changed behavior; identification of
molecules, responsible to induce ER stress; the pathway to link ER
stress with mitochondrial dysfunction and polarized differentia-
tion of monocyte derived macrophages. The possible cause–effect
relationship between low grade inflammation and initiation of
MS has also been discussed.
HIGH FAT ACCUMULATION IN ADIPOCYTES AND
NON ADIPOSE TISSUES
The body has inherent capacity to store extra fuel for starvation
driven emergency. The fat is the storage form of extra nutritional
calories and the adipose cells are the primary site for its deposi-
tion. However, after fat-overloading, the extra fat overflows from
these cells and get their resting destination to non-adipocytes.
This phenomenon is called ectopic fat storage. Although, fat is
deposited in all kind of tissues, but muscle and liver are the
main organs. During its transport and also in tissue, the scav-
engermacrophages keep on engulfing the fat droplets, tomaintain
the normal level as high FFA is liable to disturb the homeostasis
of the tissue. Finally, these macrophages get converted to foam
cells. The oxidized and glycated lipoproteins, free fatty acids, free
cholesterol, triacylglycerols, diacylglycerols, and ceramides are
predominant lipid intermediates, which deposit to these organs
and induce cellular dysfunction. In case of diabetes, high diacyl-
glycerols activates PKC, which further activates serine/threonine
kinases and inhibits insulin signaling (Bergman et al., 2012).
In case of normal fat deposition, peripheral and visceral
adipocytes are the primary targets. The preference to these tis-
sues is genetically governed as Asian population is more prone
to visceral fat deposition. In fact, this is a kind of adaptive pro-
cess to reduce the circulation free fatty acid in the body, which
is more harmful. It acts as the reservoir to trap high circulating
free fatty acid in the body. It is a mechanism to prevent ectopic
fat deposition, onset of fatty liver and insulin resistance. Among,
these two tissues also visceral fat is considered to be more harmful
than peripheral fat, because of its higher inflammatory nature, as
described below (Tsuriya et al., 2011).
The basic cause of inflammatory nature of these adipose tissues
is to due to high accumulation of tissue imbedded macrophages
and also because of its own cellular stresses. A report indicates that
when mice are given a restricted diet, macrophage recruitment is
unexpectedly increased in adipose tissue during the early phase of
weight loss (Kosteli et al., 2010). Thus macrophages could con-
tribute to ensure adipose tissue homeostasis and remodeling in
response to changes in energy balance and body weight alter-
ations. They display phagocytic activity against lipid droplets,
without causing inflammation, thereby contributing to restore
local lipid homeostasis. Thus, macrophage accumulation is a kind
of adaptive change. An increase in macrophage number is con-
comitant with increased lipolysis in adipose tissue and is not
associated with up-regulation of inflammatory genes.
ADIPOCYTES AND INFLAMMATION
The inflammatory role of adipocytes is related to its expan-
sion, hyperplasia and hypertrophy. They involve variety of
cellular stresses like endoplasmic reticulum (ER) stress, mito-
chondrial dysfunction, oxidative stress etc. These factors change
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FIGURE 1 | Inflammatory and metabolic pathways in adipocytes. These
pathways are induced by intracellular and extra-cellular signals. In
hypertrophied adipocytes, infiltration of macrophages increases, resulting to
increased expression of genes involved in inflammatory cascade. On
hyperphagia, ER stress increases in cells which is linked with mitochondrial
dysfunction and release of cytokines.
the secretion property of adipocytes, which can be assessed
through altered secretion profile of adipokines. They act locally
(autocrine/paracrine) and also systemically (endocrine). In nor-
mal conditions, there are three main adipokines, i.e., (a) leptin,
(b) adiponectin, and (c) resistin, but in fat-overloading, these
adipocytes secrete additional inflammatory cytokines and free
fatty acid. They express novel receptors for various endocrine
and neural signals (Kershaw and Flier, 2004). They attract
more macrophages (Weisberg et al., 2003), which get imbed-
ded into adipose tissues. Thus, cluster of macrophages with
adipocytes are form a crown-like structures (CLSs) which are
more inflammatory.
The Adipocytes hypertrophy behaves as the source and tar-
get of inflammatory signals. It induces expression of TNF-α,
IL-6, IL-1β, PG-E2, etc (Apovian et al., 2008). These adipocytes
secrete some novel cytokines, which convert a subset of circu-
lating monocyte to macrophages (Ronti et al., 2006). There is
low secretion of adiponectin, which enhances the process of hep-
atic necrosis and inflammation. Eventually, this hypertrophy leads
to adipocyte’s death and the release of cellular contents into the
extracellular space, which further attracts macrophages (Cinti
et al., 2005) and persistent activation of neutrophils, monocytes,
and T-cells.
In obesity, the plasma level of C-reactive protein (CRP) is
high, which is largely synthesized by the liver. Its synthesis is
enhanced in response to all inflammatory cytokines, described
above. The CRP further amplifies the pro-inflammatory effects
of other adipokines. Besides inflammation, the adipocytes also
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possess oxidative stress and release heme oxygenase-1 (ho-1)
and show low plasma superoxide dismutase (SOD) activity. The
oxidative stress is associated with high hydrogen peroxide (H2O2)
accumulation and high expression of NADPHoxidase-IV. At later
stage, high urinary TBARS and change in urinary pH have been
noted. The ER also contributes to oxidative stress by free radical
generation. It is through activation of protein disulfide isomerase
(PDI), which catalyzes disulfide bridge formation (Schroder and
Kaufman, 2005).
In various reports, it was suggested that as adipose tissue mass
expands in obesity, clusters of enlarged adipocytes become dis-
tant from the vasculature, leading to local pockets of hypoxia
(Trayhurn and Wood, 2004). Hypoxia-inducible factor-1α (HIF-
1α) is induced in human adipocytes by hypoxia and is regarded as
“a master hypoxia signal mediator” (Semenza, 2002; Wang et al.,
2007). Hypoxia in turn induces the gene expression of inflamma-
tory markers in adipocytes and macrophages. The induced genes
include TNF-α, interleukins (IL)-1, IL-6, monocyte chemoattrac-
tant protein-1 (MCP-1), and plasminogen activator inhibitor-1
(PAI-1).
OBESITY AND MACROPHAGE INFILTRATION
The adipose tissues in obese persons are associated with raised
leptin (Levin, 2005) and low adiponectin in plasma (Bouhali
et al., 2008). Enlarged adipose tissue recruits macrophages and
lymphocytes (Kewalramani et al., 2011). Later on they undergo
apoptotic process and also release inflammatory cytokines and
chemo-attractants. Increased accumulation of macrophages is
due to influx of its bone marrow–derived precursors to adi-
pose tissue and their subsequent differentiation into mature
F4/80-expressing macrophages. The presence of CD68-positive
macrophages in direct contact with mature adipocytes has been
noted more in visceral fat than in subcutaneous peripheral fat
(Levin, 2005).
Release of MCP-1 and macrophage colony stimulating fac-
tor (M-CSF) are major mediators for macrophage accumulation.
Transgenic expression of MCP-1 also known as chemokine lig-
and 2 (Ccl2), in adipose tissue increases macrophage infiltration,
inflammation, and insulin resistance (Kaufman, 1999; Munzberg
and Myers, 2005; Brennan et al., 2007). Conversely, disruption of
MCP-1 or its receptor CCR-2 impairs migration of macrophages
into adipose tissue, thereby lowering adipose tissue inflammation
and improving insulin sensitivity (Baskin et al., 1999; Kaufman,
1999).
At one hand adipocytes undergo ER stress due to high lipid
accumulation and metabolism, thereby some of them are under-
going apoptosis, but on the other hand, the tissue imbedded
macrophages trap the fat droplets and also engulf the dead
adipocytes through phagocytes. This process is associated with
respiratory burst and release of high amount of free radicals.
This high volume of reactive oxygen species (ROS) further
enhances the mitochondrial dysfunction, ER stress, and cyto-
plasmic pH change. All these factors induce a cellular stress,
which changes the phenotype of adipocytes, resulting to high
secretion of adipokines. At paracrine level, these secretions alter
the macrophage-phenotype. They undergo polarized differenti-
ation between pro-inflammatory M1 type (classically activated
macrophages) and non-inflammatory M2 type (alternative acti-
vated macrophages) (Figure 1). The expression of CD36 in both
macrophages and adipocytes, enhances adipose tissue inflamma-
tion and cell death in diet-induced obesity.
The phenotypic change in macrophages, between M1 and
M2, differs in obese and lean animals. It is predominantly
dependent on the local cytokine released in that tissue, where
these macrophages are embedded. In lean mice, the imbedded
macrophages have high expression of F4/80+CD11c+ proteins,
characteristic of M2 macrophages. However, in obese mice, these
expressions are low and here M1 macrophages are predomi-
nant. They are inflammatory in nature and has characteristic
gene expression of TNF-α and iNOS, IL-1β, CXCL10, and IL-6.
The M1 macrophages limit the adipocyte hypertrophy (Lumeng
et al., 2007) and inhibit adipogenesis and increase the extracel-
lular matrix deposition in pre-adipocytes (Keophiphath et al.,
2009). Hence, inhibition of adipogenesis combined with a pro-
fibrotic phenotype of pre-adipocytes strengthens the role of pro-
inflammatory macrophages to restrain adipocyte size. Because of
local release of cytokines by adipocytes, large numbers of immune
cells, including monocytes and T-lymphocytes, are aggregated in
adipose tissue (Moller and Kaufman, 2005).
Macrophages are classically stimulated by interferon-γ
(IFN-γ) alone or in combination with lipopolysaccharide (LPS)
and they produce inflammatory cytokines (e.g., IL-1, IL-6, and
TNF-α), which are capable of inducing Th1-polarized T-cell
responses. The adipocytes, undergoing necrosis, secondary
to hypertrophy, also lead to macrophage activation (with the
accompanying release of inflammatory mediators) and their
subsequent clearance from adipose tissue (Levin, 2005). It may
lead to systemic insulin resistance, as reported in diet-induced
animal model (Alkhouri et al., 2010; Kanda et al., 2006).
ENDOPLASMIC RETICULUM (ER) STRESS
The ER is a critical site of protein, lipid and glucose metabolism,
lipoprotein secretion, and calcium homeostasis. It is mainly rec-
ognized as a protein-folding factory and involved in lipid synthe-
sis, protein folding, and maturation. It also helps in biosynthesis,
folding, and modification of numerous soluble and membrane
bound proteins (Kaufman, 1999). Most of the newly synthe-
sized proteins are transported to the lumen of the ER, for proper
folding for their target places in the cell. Many signal sequences
define the pathway of Proteins transport from ER to the cell. A
few amino acids of N-terminus work as an address tag, which
are removed when the polypeptide reaches to its destination.
Proteins that are destined for places outside the ER are packed
into transport vesicles and moved along the cytoskeleton toward
their destination. The smooth endoplasmic reticulum (SER) has
many functions as, synthesis of steroids, metabolism of carbohy-
drates, regulation of calcium concentration, drug detoxification,
attachment of receptors on cell membrane proteins, and steroid
metabolism (Tsuriya et al., 2011).
Thus ER stress is referred as a condition, where accumula-
tion of unfolded or misfolded proteins in ER lumen. This is
called Unfolded Protein Response (UPR). The improper-folded-
proteins, released due to ER stress, do not reach to Golgi appara-
tus, but released in cytosol, for their degradation by proteosomes.
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The N-glycosylated proteins in the ER regulate the folding qual-
ity. Genetic over expression of the ER chaperones ORP150
(oxygen-regulated protein-150) and GRP78 (glucose-regulated
protein-78) improves metabolic regulation in mice. Moreover,
treatment of insulin-resistant humanswith TUDCA, a conjugated
bile acid derivative that inhibits ER stress—induced apoptosis,
results in increased insulin sensitivity (Kars et al., 2010). The
observation that treatment with chemical ER chaperones reduces
both obesity/insulin resistance and atherosclerosis inmice further
supports this conclusion. ER stress transcript HSP-A5, which is
high with increased BMI (Wang et al., 2009).
ER stress in adipose tissue may be due to nutrient over-
load, along with increased demand for protein synthesis for
its metabolism, local glucose deprivation due to insulin resis-
tance, and decreased vascularization. There is excessive protein
traffic or by excess accumulation of unfolded protein aggre-
gates, collectively known as the UPR. It is also an adap-
tive step but high UPR initiates inflammation (Achard and
Laybutt, 2012). High-fat diet also induces ER stress in other
tissues also. It has been linked to ER stress in the hypothala-
mus, through high protein kinase-like ER kinase (PERK) phos-
phorylation (Özcan et al., 2004). In turn, it leads to insulin
resistance and Type 2 diabetes (Harding et al., 2001). Here,
high FFA also down regulates PPARγ protein and its mRNA
(Haukeland et al., 2012). ER stress can be measured through
other key indicators such as HSPA5 (heat shock protein-A-5),
CHOP (C/EBT-homologous Protein), ERN1, and GADD34.
There are other ER stress marker genes also e.g., Atf4, activat-
ing transcription factor 6 (Atf6), Xbp1s, and inositol-requiring
protein-1α phosphorylation as well as changes in eIF2α phos-
phorylation (Boyce et al., 2005). Besides, these UPR markers,
it has been reported that ATF6α expression is reduced in the
liver of obese mice under ER stress. Its reconstitution through
adenoviral-ATF6α, improves glucose homeostasis in these ani-
mals (Zhang et al., 2002). This suggests a possible dissociation
between chaperone production to enhance protein processing
and other UPR-mediated signaling events that could underlie
some of the detrimental metabolic effects seen in obesity. Hence,
a mild balance between glucose levels and the UPR needs to be
maintained.
Similarly, cholesterol induces ER stress in liver, via high activ-
ity of Lecithin:Cholesterol acyltransferase (Hager et al., 2012).
Cholesterol, either synthesized in the ER or derived from the diet,
contributes to cell membranes. The whole process of cholesterol
trafficking involves ER activation. There is high release of ER cal-
cium and ROS generation in cholesterol overloaded macrophage
(Pahl and Baeuerle, 1997). Here, three ER stress sensors are acti-
vated e.g., PERK, IRE1α, and ATF6, along with their downstream
effectors-molecules. The overload with unesterified cholesterol
in the ER membranes of macrophages decreases the calcium
store of ER (Feng et al., 2003), resulting to ER stress and UPR.
They form the foam cells, which are inflammatory in nature and
induce the synthesis of pro-inflammatory cytokines (TNFα and
IL6), by activating the nuclear factor kappa B (NF-kB) and the
mitogen-activated protein kinases-mediated inflammatory path-
ways (Li et al., 2005). Here, CHOP, the target of PERK-mediated
UPR pathway, is required (Li et al., 2005).
High activity of lipoprotein lipase (LPL) also initiates ER
stress. Diets high in refined carbohydrates have been shown
to cause tissue-specific over-expression of LPL through hyper-
insulinemia (Johansen andMalmlöf, 2006). The adipocyte-LPL is
activated by insulin and muscle LPL is activated by glucagon and
epinepherine. Therefore, fasting enhances LPL activity in mus-
cle and decreases in adipose tissue. This response is opposite to
well fed individuals. Drugs like thiazolidinedione (TZD) increases
systemic insulin sensitivity and adipose tissue triglyceride stor-
age while decreasing its fatty acid efflux. Insulin activates LPL in
adipose tissue but decreases in muscle (Shearer et al., 2011).
The ER of adipocytes plays a major role in the assembly and
secretion of adipokines. The ER stress significantly decreases the
adiponectin mRNA expression. Further ER stress also induces
“leptin resistance.” High homocysteine level also induces ER stress
(Kokame et al., 2000; Zhang et al., 2008), resulting to leptin resis-
tance (Delépine et al., 2000). Thus all these phenomena lead to
insulin resistance.
It has been reported that SOCS-3 (suppressor of cytokine
signaling-3) (Cheng et al., 2002; Zabolotny et al., 2002) or PTP-1B
(protein tyrosine phosphatase-1B) (Outinen et al., 1999; Hosoi
et al., 2008) are involved in leptin resistance. In liver, ER stress
increases expression of hepatic gluconeogenic enzyme. This path-
way is also involved in suppression of hepatic gluconeogenic
enzymes, which is via JAK2 dephosphorylation and HDAC-
dependent STAT3 deacetylation. Thus, it increases the hepatic
glucose production in obesity and diabetes (Kimura et al., 2012).
The fatty acid-binding proteins (FABPs), especially FABP4 and
FABP5, a family of lipid chaperones, play significant roles in
promotion of metabolically triggered inflammation known as
metaflammation inMS linked diseases, which is high in ER stress.
The ER stress is also found in hyperglycemia. It is because
of high insulin demand. It allows the entry of new pro-insulin
into the ER for maturation. On continuous increase of blood
glucose, pro-insulin translation is raised along with high UPR.
This results to activation of secretion capacity of the ER for active
insulin (Scheuner et al., 2005). Since, these cells are very rich
in ER network, because of high turnover of insulin protein in
this organ, so ER stress significantly compromises its function.
In pancreatic β cells, low blood glucose activates PERK medi-
ated UPR pathway, due to low energy for protein folding in the
ER. This results to translational attenuation to reduce the ER
workload. When blood glucose levels increases, the UPR path-
ways are deactivated, resulting to accelerated translation. It is
reported that pre-existence of mild ER stress, predisposes β-cells
to an exacerbated inflammatory response when exposed to IL-
1β or TNF-α, cytokines that contribute to the pathogenesis of
type 1 diabetes (de Oliveira et al., 2012). These cells show more
intense and protracted inflammatory response through inositol-
requiring enzyme 1/XBP1 activation (Miani et al., 2012).
There is suppression of protein synthesis and stimulation of
lipid synthesis in the ER of obese animals, without significant
alterations in chaperone content. The ER chaperone proteins
play important role in correct folding of newly synthesized pro-
tein. These chaperones are disulfide isomerase (PDI), ERp29, the
Hsp70 family member Grp78, calnexin, calreticulin, and the pep-
tidyl propyl isomerase family. ER stress is suggested to be the
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proximal cause of inflammation in adipocytes, PTP1B expression
levels, involved in the ER stress response, are increased in adi-
pose tissue of obese, high-fat-diet-fed mice (Shearer et al., 2011).
The ER is also involved in xenobiotic detoxification and dynamic
calcium storage. The activation of rapamycin activity is another
condition leading to ER stress. It is highly activated in obesity,
especially in metabolically active tissues like liver, adipose tissue,
and pancreatic islets (Ozcan et al., 2006).
ER stress is associated with inflammation. The 12/15-
lipoxygenase enzyme (12/15-LO) mediated pathway has been
reported to be disturbed in adipocytes, pancreatic islets, and
liver cells during ER stress. It promotes inflammation and insulin
resistance in adipose and peripheral tissues. It acts through high
expression of BiP, XBP-1, p-PERK, and p-IRE1α, which are sim-
ilar to expression induced by tunicamycin or thapsigargin, a
known ER stress inducer (Cole et al., 2012).
The induction of inflammation by independent Toll-like
receptor 4/2-pathway has been reported due to ER stress, induced
by intracellular accumulation of stearic acid. It finally induces
apoptosis in adipocytes. It is via activation of JNK pathway and
depletion in ER Ca++. Use of its inhibitors has reduced the
apoptosis in adipocytes. Further, blocking the transcription fac-
tor CHOP also delays such apoptosis. Alterations in ER fatty
acid and lipid composition inhibit the sarco/ER calcium ATPase
(SERCA) activity resulting to ER stress. Here, ER stress sen-
sors IRE1 (the inositol-requiring ER-to-nucleus signal kinase 1),
PERK, and ATF6 are activated, resulting to reduction of transla-
tion and increase in transcription of ER chaperones to ensure the
normal cell function.
The ER stress is also associated with dysfunction in the
exocrine pancreas, resulting to diabetes (Delépine et al., 2000).
Moreover, hyperglycaemia in the diabetic Akita mouse was found
to be accompanied by CHOP expression and the apoptosis of
β-cells. In addition, the deletion of CHOP has been shown to
reduce oxidative stress, improve β-cell function and promote cell
survival in multiple mouse models of diabetes (Xu et al., 2003).
These results suggest that ER stress is involved in diabetes and that
several ER-stress-related genes are involved in these processes.
There is direct or indirect induction of ER stress response by
advanced glycation end products (AGEs). The advanced glyca-
tion is the major posttranslationalmodification of proteins, DNA,
and lipids. It is accelerated under conditions of increased oxida-
tive stress, hyperglycemia, and hypoxia. It contributes to a variety
of metabolic diseases such as diabetes mellitus, obesity, inflam-
mation, polycystic ovarian syndrome, ischemic cardiovascular
disease, and neurodegenerative disorders. Inhibitors of advanced
glycation, acting as potent ER stress modulators, show beneficial
effects and restores ER homeostasis. It is emerging approach to
treat MS. Thus, a crosstalk between Advanced Glycation and ER
Stress has been reported (Piperi et al., 2012).
The ER-stress also induces autophagy in adipocytes. It is
another way for manifestation of obesity-induced insulin resis-
tance and type-2 diabetes. The UPR activates the ER-associated
degradation (ERAD) system so that miss-folded/unfolded pro-
teins get transported from the ER lumen to the cytosol for
subsequent degradation, through autophagy-dependent pathway.
Autophagy is a pathway for cellular defense mechanism, where
recycling of nutrients and energy takes place for cell survival.
During autophagy, cytoplasmic constituents are sequestered into
double membrane vesicles (autophagosomes) that subsequently
fuse with lysosomes for degradation (Zhou and Liu, 2010).
INTERACTION BETWEEN ER STRESS AND
MITOCHONDRIAL DYSFUNCTION
The ER oxidative stress. It generates ROS, via activation of PDI,
an enzyme which catalyzes disulfide bridge formation and in the
process generates ROS (Cinti et al., 2005). ER stress is linked
to mitochondrial dysfunction through modulated Ca2+ signaling
(Szabadkai and Duchen, 2008). The releases of Ca2+ from the ER
lumen, leads to increased Ca2+ uptake by mitochondrial matrix.
It induces an imbalance between mitochondrial Ca2+ load and
the buffer concentration of the matrix. Such imbalance causes
a prolonged mitochondrial Ca2+ accumulation and opening of
mitochondrial permeability transition pore (mtPTP). It finally
causes mitochondrial swelling, breaking of the OMM, and release
of pro-apoptotic proteins into the cytoplasm (Deniaud et al.,
2008).
During excess fat/carbohydrate intake, adipocytes initiate the
process of glyceroneogenic and lipogenic steps at higher rate.
This is supported by supplies of its precursors e.g., pyruvate,
lactate, and alanine, which involves high activity in mitochon-
dria through activation of pyruvate carboxylase. ATP, reducing
cofactors and Acetyl-CoA are the obligatory cofactor for these
pathways (Yen et al., 1977). The availability of ATP directly regu-
lates the rate of lipogenesis in adipose tissue is the ATP availability
as One acetyl-CoA moiety formed from pyruvate and incorpo-
rated into fatty acids requires three molecules of ATP. Thus, ATP
depletion may retard lipogenesis. Contrary to this ADP inhibits
this process thus ATP:ADP ratio is important. The activity of
pyruvate carboxylase in mitochondria of rat adipose tissue is
greater than the concentration, found in mitochondria of liver.
This whole process imparts a kind of stress to mitochondria,
which produces more superoxides as byproduct. Thus a kind of
oxidative stress is generated within the cells of adipose tissue,
which further initiates ER stress and inflammatory process.
The ER stress mediated mitochondrial dysfunction is also
mediated by nitric oxide (NO) production (Xu et al., 2004). In
competition with oxygen, NO can bind to cytochrome C oxidase
and inhibits its activity (Brown, 2001). It changes the Ca2+ move-
ment between mitochondria and ER. Further the NO mediated
changes in Ca2+ flux, increases expression of ER stress responsive
genes such as glucose regulated protein-78 (Grp-78). Similarly,
the mitochondrial dysfunction in muscle is associated with the
onset of insulin resistance and type 2 diabetes.
Cysteine is the most reactive amino acid in protein and
wide ranges of cysteine derivatives are formed in vivo, result-
ing from oxidation, nitrosation, alkylation, and acylation reac-
tions. Similarly, succination of proteins takes place, which is
an irreversible chemical modification of cysteine by the Krebs
cycle intermediate, fumarate, and yielding S-(2-succinyl) cys-
teine (2SC). It is increased due to hyperpolarization of the
inner mitochondrial membrane and develops mitochondrial and
oxidative stress. The succination of glyceraldehyde-3-phosphate
dehydrogenase has been found to be raised in the muscle of
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streptozotocin-diabetic rats. There is also increased succination of
adiponectin, which results to decreased secretion of adiponectin
from adipose tissue in type-2 diabetes. Thus, 2SC serves as a
biomarker of mitochondrial stress. It serves as the mechanistic
link between mitochondrial and ER stress in diabetes.
Contrary to above facts, mitochondrial dysfunction also
induces ER stress. Since, large amount of ATP is required for
both protein folding and handling of Ca2+ within the ER, so in
its scarcity ER stress is induced (Kaufman, 2002). The inhibition
of oxidative phosphorylation causes delay in uptake of Ca2+ into
the ER-lumen. This low level of Ca2+ within the ER inhibits the
oxidative phosphorylation, resulting to rapid ATP depletion in
mitochondria and the ER. When this condition is prolonged, the
cytosolic ATP level decreases. Some studies show that ROS acts
as a local messenger between ER and mitochondria (Csordás and
Hajnóczky, 2009). Large number of ROS sources and targets are
located in ER and mitochondria (Malhotra and Kaufman, 2007).
In folding of newly synthesized ER, the oxidoreductin 1 (Ero1)
protein-family mediated formation of disulfide bond is a criti-
cal step, which is activated in ER stress (Harding et al., 2003).
Further, due to excessive production of ROS in the ER, the Ca2+
ATPase (SERCA) of sarco-ER gets inactivated and IP3R gets acti-
vated (Adachi et al., 2004). The ROS also changes Ca2+ channel
activity of ER, which increases the level of Ca2+ on the cytosolic
face of the ER. Thus ROS mediated Ero1 expression provides an
additional mechanism by which ER stress induces mitochondrial
dysfunction.
THERAPEUTIC TARGET AND THERAPIES FOR
MANAGEMENT OF CELLULAR STRESSES
Several studies have targeted signals involved in the inflammatory
process of obesity. It includes inhibition of expression of inflam-
matory cytokines, modulation of ER stress and mitochondrial
stress, apoptotic process mediated signals in adipocytes, infiltra-
tion and phenotypic modification of adipose tissue macrophages,
liver function, with reference to visceral fat accumulation etc., the
steps involved for augmentation of the process of protein folding,
modulation of protein chaperones to curve down the produc-
tion of abnormal proteins and UPR. Down regulation of Ca++
release from ER and attenuation of ER protein synthesis, through
inhibition of eIF2alpha dephosphorylation are other approaches.
It decreases the ER protein translation and reduces apoptosis
(Gregor and Hotamisligil, 2007).
The PPAR-γ is a target, because its activation decreases the size
of adipocyte and improves the insulin sensitivity on skeletal mus-
cle (Hsueh and Bruemmer, 2004). It also decreases ER protein
synthesis by increasing eIF2alpha phosphorylation. Some PPAR-
γ agonists increase the uptake of free fatty acids into the fat cell as
they promote fat cell differentiation and decrease inflammatory
markers. They also increase adiponectin expression (Ofei et al.,
1996; Hsueh and Bruemmer, 2004).
The neutralization of TNF-α in obese rodent IS reported
to improve the glycemic control and dyslipidemia (Ma et al.,
2004). Plasminogen activator inhibitor 1 (PAI-1) the most impor-
tant inhibitor of fibrinolysis, is synthesized predominantly in
vascular tissues, liver, and visceral adipose tissue. The PAI-1-
deficient mice are protected against insulin resistance and obesity.
The antagonists of angiotensin AT1 receptors, down regulate PAI-
1 and improves diet-induced obesity and hyperglycemia in mice
(Williams, 2012). Thus, regulators of PAI-1, which include regula-
tors of the renin–angiotensin system (RAS), might have beneficial
effects in the prevention and treatment of cardiometabolic dis-
ease. Thus, drugs, which induce LPL expression in non-hepatic
tissue, may be helpful in its management.
The treatment of diabetic animals with 17β-oestradiol
also protects pancreatic β cells against oxidative stress, amy-
loid polypeptide toxicity, lipotoxicity, and apoptosis. Similarly,
reduced testosterone level is related to obesity, insulin resistance,
type 2 diabetes, heart disease, benign prostatic hypertrophy, and
even prostate cancer. In the final stage of the steroidogenic cas-
cade, testosterone is metabolized to oestradiol by P450 aromatase,
in the cytoplasm of adipocytes, breast cells, endothelial cells,
and prostate cells, to increase intracellular oestradiol concentra-
tion at the expense of testosterone. The stress, xeno-oestrogens,
poor dietary choices, and reactive toxins up-regulate aromatase
to increase intracellular oestradiol production. Thus, the raised
intracellular oestradiol levels in men, promote these pathologies
(Kumar et al., 2012).
The inhibition of succination of adipocyte protein would be
helpful in managing cellular stress. It can be achieved by using
un-couplers of oxidative phosphorylation and by inhibitors of ER
stress. Since, ER involves the release of cellular Ca++, which leads
to activation of calpain and caspase-12 and cleavage of fodrin,
so use of Bapta-AM (a cell permeable Ca++ specific chelator),
or calpeptin (a calpain inhibitor) would prevent this ER stress
and mediated apoptosis. The Ruthenium red, an inhibitor of
mitochondrial Ca++, uniporter, and also prevents apoptosis by
inhibiting the subsequent mitochondrial dysfunction. Similarly,
Diospyrin diethylether (D7), a bisnaphthoquinonoid derivative,
exhibits an oxidative stress-dependent apoptosis in several human
cancer cells and tumor models (Fullwood et al., 2012).
The eIF2α phosphatases prolong eIF2α phosphorylation and
thus reduce the cell death showing significant cyto-protection
in several neurodegenerative disorders. Thus, it may be used
as a potential strategy for future drug development to treat
human proteinmis-folding disorders (Jung et al., 2012). Similarly,
Subtilase cytotoxin (SubAB), leads to ER stress and apoptosis by
cleaving the molecular chaperone BiP in the ER. It is mediated
by RNA-dependent protein kinase (PKR)-like ER kinase (PERK).
Thus, treatment with proteasome inhibitors (i.e., MG132 and
lactacystin) may be helpful. Further, Metformin, directly pro-
tects against dysfunction and death of ER stress-induced NIT-1
cells (a mouse pancreatic beta cell line) via AMP-activated pro-
tein kinase (AMPK) and phosphatidylinositol-3 (PI3) kinase
activation (Isa et al., 2011).
Since NO-induced apoptosis in beta-cells of pancreas, is medi-
ated by the ER-stress pathway by inducing CHOP (ER stress-
associated apoptosis factor), so NO scavengers may be indirectly
helpful in this mission. The antimycin or oligomycin are known
to induce Metabolic stress in pancreatic β-cells. The impaired
mitochondria dysfunction increases ER stress. Proteins such as
p-eIF2α, GRP78 and GRP 94, CHOP activate JNK, and AMPK
is involved in this process. Thus, its inhibition with any com-
pound such as Compound-C, may block the ER stress and there
Frontiers in Immunology | Inflammation August 2012 | Volume 3 | Article 240 | 6
Tripathi and Pandey Obesity and ER stress
by decrease the β-cell apoptosis. Similarly, those drugs which
could reduce the cholesterol uptake and increase cholesterol efflux
from macrophages, could suppress the ER stress and could be
used as a potential therapy for atherosclerosis. In case of T-2
DM patients, there is predominance of the M1 over M2 phe-
notype in peripheral blood monocytes (Oh et al., 2012). Thus,
suppression of ER stress would decrease the vascular inflamma-
tion and there by prevents the development of atherosclerosis
(Bouhlel et al., 2009). Stimulation of PPARγ and PPARδ would
also facilitate the transformation of undifferentiated macrophages
to the alternatively activated M2 phenotype, there by inhibiting
the activation of macrophage mediated inflammatory pathway
(Tsukano et al., 2010). Since, ER stress also promotes insulin
resistance, generating a vicious cycle that leads to plaque insta-
bility, so its suppression would be helpful in management of
diabetes and vulnerable plaque management (McAlpine et al.,
2010).
The use of herbal medicines is on continuous rise for man-
agement of life style related metabolic disorders. These prepa-
ration are being used both as medicine and also as food
supplements. Most of these preparations possess antioxidant and
anti-inflammatory property, due to presence of high poly phe-
nolic compounds, so it would be logical to explore these plant
extracts and also pure phytochemicals on management of ER
stress. This part has not been fully exploited for novel drug
development, but it has a great potential. Herbs like Pueraria
Tuberose (Pandey et al., 2007), Rubia Cordifolia (Tripathi and
Singh, 2007), Vitex nigundo Linn. (Tiwari and Triapthi, 2007),
Commiphora mukul (Singh et al., 2005), Cinnamomum tamala
Linn (Chaurasia and Tripathi, 2010), and Nigella Sativa (Tripathi
et al., 2012) have already been reported to have strong antioxidant
potential. They are able to trap the free radicals and also capable
of chelating the metals.
CONCLUSION
High nutritional load attracts induces ER stress and change the
profile of chemokine release by adipocytes. These secretions,
induce the phenotypic change in macrophages, which further add
to the inflammatory process. The whole process leads to untimely
death of overloaded adipocytes and macrophages, which further
attracts the macrophages. Thus, prevention of ectopic and nor-
mal fat deposition would prevent the ER stress andmitochondrial
dysfunction and associated apoptosis in these cells. Further low
grade inflammation, induced by above cellular changes, could be
prevented by reversal of the ER stress especially in adipose cells
and macrophages. Many phytomolecules, which have reported
antioxidant and anti-inflammatory property could be explored
for their potential to reverse ER stress and associated inflam-
mation/apoptosis, which may be finally useful for management
of MS.
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